XML 55 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation - Stock options (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2021
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Options        
Outstanding at beginning of period (in shares)   4,408,274 3,021,799 3,021,799
Granted (in shares)   2,101,316 1,314,200  
Exercised (in shares)   (462,073) (44,105)  
Cancelled (in shares)   (893,071) (145,787)  
Outstanding at end of period (in shares) 3,021,799 5,154,446 4,146,107 4,408,274
Vested at end of period (in shares)   2,569,967 760,028  
Vested and expected to vest at end of period (in shares)   5,154,446 4,146,107  
Weighted average exercise price        
Outstanding at beginning of period (in dollars per share)   $ 3.44 $ 3.71 $ 3.71
Granted (in dollars per share)   1.06 3.46  
Exercised (in dollars per share)   0.49 0.43  
Cancelled (in dollars per share)   2.64 4.10  
Outstanding at end of period (in dollars per share) $ 3.71 2.87 2.55 $ 3.44
Vested at end of period (in dollars per share)   2.42 1.37  
Vested and expected to vest at end of period (in dollars per share)   $ 2.87 $ 2.55  
Weighted-average remaining contractual term and Aggregate intrinsic value        
Outstanding at end of period (in years) 8 years 11 months 8 days 7 years 7 months 17 days 9 years 3 months 21 days 8 years 6 months 7 days
Vested at end of period (in years)   4 years 2 months 1 day 8 years 2 months 23 days  
Vested and expected to vest at end of period (in years)   7 years 7 months 17 days 9 years 3 months 21 days  
Outstanding at beginning of period (in dollars)   $ 350 $ 10,903 $ 10,903
Outstanding at end of period (in dollars) $ 10,903 2,819 2,529 $ 350
Vested at end of period (in dollars)   1,092 1,188  
Vested and expected to vest at end of period (in dollars)   $ 2,819 $ 2,529  
Weighted average grant-date fair value of stock options granted   $ 0.62 $ 2.31